Down-regulation of the invariant V{alpha}14 antigen receptor in NKT cells upon activation

Michishige Harada1, Ken-ichiro Seino1,2, Hiroshi Wakao1, Sakura Sakata1, Yuko Ishizuka1, Toshihiro Ito3, Satoshi Kojo1, Toshinori Nakayama3 and Masaru Taniguchi1

1 RIKEN Research Center for Allergy and Immunology, Graduate School of Medicine, Chiba University, Chiba City, Chiba 260-8670, Japan 2 PRESTO, JST, Kawaguchi City, Saitama 332-0012, Japan 3 Department of Medical Immunology, Graduate School of Medicine, Chiba University, Chiba City, Chiba 260-8670, Japan

Correspondence to: M. Taniguchi, RIKEN Research Center for Allergy and Immunology, Department of Molecular Immunology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. E-mail: mtaniguchi{at}faculty.chiba-u.jp
Transmitting editor: T. Watanabe


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
NKT cells expressing the invariant V{alpha}14 antigen receptor constitute a novel lymphocyte subpopulation with immunoregulatory functions. Stimulation via their invariant V{alpha}14 receptor with anti-CD3 or a ligand, {alpha}-galactosylceramide ({alpha}-GalCer), triggers activation of V{alpha}14 NKT cells, resulting in a rapid cytokine production such as IFN-{gamma} and IL-4. Soon after their receptor activation, V{alpha}14 NKT cells disappeared as judged by staining with CD1d tetramer loaded with {alpha}-GalCer ({alpha}-GalCer/CD1d tetramer), which has been believed to be due to apoptotic cell death. Here we show that such a disappearance was largely attributed to down-regulation of the V{alpha}14 receptor. In fact, V{alpha}14 NKT cells were relatively resistant to apoptosis compared to the conventional T cells as evidenced by less staining with Annexin-V, a limited DNA fragmentation, and their preferential expression of anti-apoptotic genes such as NAIP and MyD118. Furthermore, they did not become tolerant, and maintained their proliferative capacity and cytokine production even after their receptor down-regulation. These as yet unrecognized facets of V{alpha}14 NKT cells are discussed in relation to their regulatory functions.

Keywords: {alpha}-galactosylceramide, apoptosis, CD1d tetramer, cDNA array, cytokine production


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Effector T cells are activated and proliferate to initiate immune responses upon antigen stimulation, whereas in certain milieux, they become anergic or doomed to die by apoptosis (13). In contrast, regulatory T cells, such as CD4+CD25+ cells that mediate immunosuppressive functions, have been shown to be relatively resistant to apoptosis induced by TCR stimulation (4). Moreover, stimulation of a co-receptor molecule, CTLA-4, elicits negative signals and results in the suppression of effector T cell functions, while it leads to the activation of CD4+CD25+ regulatory T cells (2,5,6). These unique features of effector and regulatory cells can be explained by cell-type-specific outcomes in response to extracellular stimuli, such as TCR engagement and/or cytokines.

V{alpha}14 NKT cells, another type of immunoregulatory cell, possess solely an invariant V{alpha}14 antigen receptor, encoded by V{alpha}14 and J{alpha}281 gene segments, that is reactive to a glycolipid antigen, {alpha}-galactosylceramide ({alpha}-GalCer), presented by CD1d (710). V{alpha}14 NKT cells play crucial immunoregulatory roles in a variety of immune responses, including protection from autoimmune disease development, maintenance of transplantation tolerance and immunological surveillance for tumors [reviewed in (11)]. However, little is known about the molecular events operating in activated V{alpha}14 NKT cells and about the destiny of V{alpha}14 NKT cells upon stimulation. Understanding the comportment of V{alpha}14 NKT cells after activation will help to elucidate the mechanisms through which V{alpha}14 NKT cells exert regulatory functions in the immune system.

In this report we show that V{alpha}14 NKT cell activation results in the rapid down-regulation of the V{alpha}14 receptor. Subsequently, V{alpha}14 NKT cells become undetectable by flow cytometry with {alpha}-GalCer/CD1d tetramer staining. Activated V{alpha}14 NKT cells remain quiescent for a while, but eventually proliferate and continue to produce cytokines. Furthermore, these cells show a resistance to apoptosis induced by TCR stimulation relative to conventional T cells. These data indicate that V{alpha}14 NKT cells neither become anergic nor are eradicated by apoptosis upon activation.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Mice
Eight- to 10-week-old female C57BL/6 mice were from SLC (Hamamatsu, Japan). C57BL/6 Ly-5.1 congenic mice were from Jackson Laboratory (Bar Harbor, ME). All mice were maintained under specific pathogen-free conditions in our animal facility; they were treated in accordance with guidelines for animal care at Chiba University.

Reagents and antibodies
{alpha}-GalCer as previously described (10) was kindly provided by Kirin Brewery (Takasaki, Japan). The following mAb were purchased from BD PharMingen (San Diego, CA): anti-CD16/32 (2.4G2) and anti-CD3 (2C11), FITC-conjugated anti-TCRß (H57-597) and anti-NK1.1 (PK136), and biotin-conjugated anti-TCRß (H57-597), Ly-5.1 (A20) and Ly-5.2 (104). Anti-FITC microbeads were purchased from Miltenyi Biotec (Auburn, CA). Phycoerythrin-labeled {alpha}-GalCer/CD1d tetramer was prepared in our laboratory using a baculovirus expression system kindly provided by Dr M. Kronenberg (La Jolla Institute, La Jolla, CA). Cells were cultured in complete RPMI 1640 medium supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 55 µM 2-mercaptoethanol (Invitrogen, Carlsbad, CA).

Preparation of dendritic cells (DC) and liver mononuclear cells
Mouse splenic DC were prepared as described previously (10). Total liver cells were suspended in a 33% Percoll solution (Pharmacia, Uppsala, Sweden) containing heparin (100 U/ml) and centrifuged at 1000 g for 15 min at room temperature. Pellets were used as liver mononuclear cells for subsequent studies after lysing red blood cells.

Stimulation with {alpha}-GalCer or {alpha}-GalCer-DC
For in vivo stimulation, 100 µg/kg of {alpha}-GalCer was i.p. injected into mice. For in vitro stimulation, DC were pulsed with 100 ng/ml of {alpha}-GalCer or vehicle alone for 24 h. After extensive washing, pulsed DC (10 x 103 cells/well) were added to stimulate spleen cells (0.2 x 106 cells/well) cultured in 96-well plates.

Flow cytometric analysis and cell sorting
Single-cell suspensions were prepared in PBS supplemented with 2% FCS and 0.05% sodium azide, pre-incubated with anti-CD16/CD32 mAb to prevent non-specific binding via Fc receptor interactions, and incubated with the appropriate mAb on ice for 30 min. Flow cytometric analysis and cell sorting were performed with Coulter Epics XL or Epics Elite cell sorters (Beckman Coulter, Palo Alto CA). Purity of sorted cells was estimated to be >98%.

Cell labeling with carboxyfluorescein diacetate succinimidyl ester (CFSE)
Electronically sorted V{alpha}14 NKT cells from Ly-5.2 mice liver (10 x 106) were incubated with 1 µM CFSE (Molecular Probes, Eugene, OR) in PBS for 8 min at room temperature. Labeling was stopped by the addition of FCS at equal volume. Labeled cells were washed extensively with medium prior to addition of Ly-5.1+ spleen cells pulsed with {alpha}-GalCer or vehicle.

Cytokine concentration measurement by ELISA
Two hundred thousand fresh spleen cells, or spleen cells incubated with {alpha}-GalCer-DC for the indicated time periods, were co-cultured for an additional 72 h with {alpha}-GalCer-DC or vehicle-DC. At the end of the incubation period, culture supernatants were collected and the concentration of IFN-{gamma} and IL-4 was measured using an ELISA kits (BD PharMingen).

Quantification of genomic DNA by PCR
Genomic DNA was extracted from cells using the QiaAmp DNA blood kit (Qiagen, Hilden, Germany). The amount of amplicons generated during PCR was monitored using the iCycler iQ Detection System (Bio-Rad, Hercules, CA). This method is based on the 5' to 3' nuclease activity of Taq polymerase, which allows the release of a fluorescent reporter during the PCR. The sequences of the primers and Taqman probes used in this study were as follows: V{alpha}14: 5'-TGG GAGATACTCAGCAACTCTGG-3'; J{alpha}281: 5'-CAGGTATGAC AATCAGCTGAGTCC-3';TCR C{alpha} exon I forward: 5'-CAGAA CCCAGAACCTGCTGT-3'; TCR C{alpha} exon I reverse: 5'-TAGG TGGCGTTGGTCTCTTT-3'; V{alpha}14 probe FAM: 5'-FAM-CACC CTGCTGGATGACACTGCCAC-TAMRA-3'; and TCR C{alpha} exon I-probe FAM: 5'-FAM-CTCCCAAATCAATGTGCCGAAAAC CA-TAMRA-3'.

Apoptosis detection assays
Electronically purified T (TCRß+NK1.1) and {alpha}-GalCer/CD1d tetramer-reactive V{alpha}14 NKT cells (TCRß+NK1.1+) from liver mononuclear cells were stimulated with plate-bound anti-CD3 mAb (10 µg/ml) for the indicated periods of time. Cells were subsequently stained with FITC-labeled Annexin-V (BD PharMingen) and analyzed with a flow cytometer. DNA fragmentation during apoptosis was monitored using the Cell Death Detection ELISA Plus kit (Roche, Mannheim, Germany).

DNA microarray analysis
Total RNA was prepared from electronically sorted hepatic T and {alpha}-GalCer/CD1d tetramer-reactive V{alpha}14 NKT cells stimulated with plate-bound anti-CD3 mAb (10 µg/ml) for 2 h. cDNA was synthesized according to the manufacturer’s instructions and labeled antisense RNA was prepared by in vitro transcription using T7 RNA polymerase (MessageAmp aRNA kit; Ambion, Austin, TX). Mouse Apoptosis Expression Arrays (R & D Systems, Minneapolis, MN) were used to interrogate the expression of murine apoptosis-related genes. Radioactive signals were detected with FLA 8000 and the quantitative analysis was performed with Image-Gage software (Fuji Film, Tokyo, Japan).

RT-PCR
cDNA was synthesized from RNA used in DNA microarray analysis with oligo-dT primer. The following primer sets were used for the RT-PCR: NAIP, 5'-TCATGACTGTGCTTGCTTCC-3' and 5'-CCAGTGGGAACGAACAGTTT-3'; MyD118, 5'-CTC CTGGTCACGAACTGTCA-3' and 5'-GGGTAGGGTAGCCTTT GAGG-3'; IL-1ß, 5'-GCCCATCCTCTGTGACTCAT-3' and 5'-AGGCCACAGGTATTTTGTCG-3'; HPRT, 5'-AGCGTCGTGA TTAGCGATG-3' and 5'-CTTTTATGTCCCCCGTTGAC-3'. The number of PCR cycles to detect the above transcripts was as follows: 28 cycles for HPRT, 35 cycles for NAIP, and 37 cycles for MyD118 and IL-1ß. PCR products were visualized by ethidium bromide staining and subjected to DNA sequencing to verify authenticity.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Down-regulation of the invariant V{alpha}14 receptors upon activation
To monitor the behavior of V{alpha}14 NKT cells upon receptor activation, {alpha}-GalCer was injected i.p. into C57BL/6 mice, and the number of V{alpha}14 NKT cells in the spleen, liver, bone marrow and thymus was examined (Fig. 1). V{alpha}14 NKT cells detected by {alpha}-GalCer/CD1d tetramer represented ~1% of the total spleen cells prior to {alpha}-GalCer administration (Fig. 2A, day 0). However, the injection of {alpha}-GalCer made V{alpha}14 NKT cells virtually undetectable within 24 h (Figs 1 and 2A, cf. day 0 and 1, 1.1–0.1%). It was not until day 3 that V{alpha}14 NKT cells robustly reappeared, occupying up to 6.2% of spleen cells. After day 4, the number and proportion of V{alpha}14 NKT cells gradually declined, and reached normal levels by day 14 (Figs 1 and 2A). Such a homeostasis of V{alpha}14 NKT cells after {alpha}-GalCer stimulation in vivo was also observed in other organs such as liver and bone marrow, but not in the thymus (Fig. 1). Challenging spleen cells with {alpha}-GalCer-pulsed DC ({alpha}-GalCer-DC) in vitro resulted in a similar behavior of V{alpha}14 NKT cells (Fig. 2B), whilst vehicle-pulsed DC (vehicle-DC) had no effect (data not shown). The apparent disappearance of V{alpha}14 NKT cells in vitro occurred within 120 min after the addition of {alpha}-GalCer-DC (see Supplementary data available at International Immunology online). Thus, the receptor-mediated disappearance of V{alpha}14 NKT cells was observed in a manner dependent on an antigen in vivo and in vitro.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1. Kinetics of V{alpha}14 NKT cells from different organs after stimulation with {alpha}-GalCer in vivo. Mice were injected with {alpha}-GalCer (100 µg/kg). After different periods of time, spleen, thymus, liver and bone marrow were removed, and the cells stained with anti-TCRß and {alpha}-GalCer/CD1d tetramer. Absolute numbers of V{alpha}14 NKT cells were calculated from the flow cytometric data. Mean values from three independent mice are indicated.

 


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 2. Comportment of V{alpha}14 NKT cells upon {alpha}-GalCer stimulation. (A) Kinetics of disappearance and repopulation of V{alpha}14 NKT cells after {alpha}-GalCer stimulation in vivo. Spleen cells from C57BL/6 mice before and after administration of {alpha}-GalCer (100 µg/kg) were analyzed by flow cytometry at the indicated time. The percentage of V{alpha}14 NKT cells, defined as TCRß and {alpha}-GalCer/CD1d tetramer-reactive cells, is indicated. Representative data from three independent experiments are shown. (B) Kinetics of cell disappearance and repopulation of V{alpha}14 NKT cells after {alpha}-GalCer stimulation in vitro. Spleen cells from C57BL/6 mice were co-cultured with {alpha}-GalCer-DC for the indicated periods of time in vitro. V{alpha}14 NKT cells were identified as described in (A). Representative data from three independent experiments are shown.

 
To preclude the possibility that the invariant V{alpha}14 receptor was occupied by {alpha}-GalCer on DC and thereby could not be detected by {alpha}-GalCer/CD1d tetramer, V{alpha}14 NKT cells were stimulated with plate-bound anti-CD3 mAb and subjected to the same experiments. It turned out that anti-CD3 mAb stimulation also culminated in similar results (see Supplementary data). These data indicate that the apparent disappearance of V{alpha}14 NKT cells was not caused by occupation of the invariant V{alpha}14 receptor with {alpha}-GalCer on DC. The tonic expansion observed in the in vitro culture (Fig. 2B), where there was no supply of V{alpha}14 NKT cells, prompted us to hypothesize that {alpha}-GalCer/CD1d tetramer-reactive V{alpha}14 NKT cells disappear, causing down-regulation of the V{alpha}14 receptor, but are not eliminated.

To examine this hypothesis, we carried out a kinetic PCR analysis to rigorously measure the quantity of rearranged genomic V{alpha}14–J{alpha}281 upon receptor activation (Fig. 3A). When the relative numbers of V{alpha}14–J{alpha}281 genomic copies were compared after an appropriate compensations had been made using C{alpha}, there was no change up to day 2, whereas the curve for the day 4 culture shifted to the left (equivalent to 3.5 PCR cycles). These results showed that there was no significant decrease in the number of V{alpha}14–J{alpha}281 genomic copies during the culture periods from day 0 to 2, implying that most of the V{alpha}14 NKT cells were alive without significant cell death (Fig. 3A, left panel). The net increase in V{alpha}14 NKT cell number upon stimulation was estimated to be in the range of 11-fold over 4 days (Fig. 3A, right panel).



View larger version (43K):
[in this window]
[in a new window]
 
Fig. 3. Down-regulation of the invariant V{alpha}14 receptor and survival of V{alpha}14 NKT cells after {alpha}-GalCer stimulation. (A) Quantification of rearranged V{alpha}14–J{alpha}281 genomic DNA. The relative amounts of V{alpha}14–J{alpha}281 (left panel, upper) and TCR C{alpha} (left panel, lower) genomic DNA from spleen cells stimulated with {alpha}-GalCer-DC were quantified by means of real-time PCR using Taqman probes. The amounts of rearranged V{alpha}14–J{alpha}281 genomic DNA were first compensated with that of TCR C{alpha} and relative amounts of V{alpha}14–J{alpha}281 genes were calculated using an external standard prepared from V{alpha}14 NKT hybridoma cells (data not shown). Relative amounts of genomic V{alpha}14–J{alpha}281 are plotted (right panel). Representative data from three independent experiments are shown with SD. (B) Study of V{alpha}14 NKT cell destiny using Ly-5.1 and Ly-5.2 C57BL/6 mice. Electronically sorted liver V{alpha}14 NKT cells from Ly-5.1 mice were mixed with spleen cells from Ly-5.2 mice at a ratio of 1:9 and co-cultured with {alpha}-GalCer-DC. The expression of the invariant V{alpha}14 receptor was monitored with {alpha}-GalCer/CD1d tetramer. The percentage of cells in each subset is indicated. Representative data from two independent experiments are shown. (C) Cell division of V{alpha}14 NKT cells after {alpha}-GalCer stimulation. Electronically sorted liver V{alpha}14 NKT cells from Ly-5.2 mice were labeled with CFSE, mixed with Ly-5.1+ spleen cells at a ratio of 1:9 and pulsed with {alpha}-GalCer or vehicle. The cell division of Ly-5.2+ V{alpha}14 NKT cells was monitored at the indicated time points after stimulation. Representative data from two independent experiments are shown. N.D. = not determined

 
The above data suggested that V{alpha}14 NKT cells survive after stimulation rather than succumbing to death. To further explore this possibility, liver NK1.1+ TCRß+ cells (of which >90% are {alpha}-GalCer/CD1d tetramer-reactive V{alpha}14 NKT cells) from Ly-5.1 mice were purified by electronic cell sorting, mixed with Ly-5.2+ spleen cells and stimulated with {alpha}-GalCer-DC. While Ly-5.1+ V{alpha}14 NKT cells expressed the invariant V{alpha}14 receptor prior to stimulation, administration of {alpha}-GalCer-DC led to down-regulation of their invariant V{alpha}14 receptor by day 2, resulting in a significant decrease in the number of Ly-5.1+ V{alpha}14 NKT cells (Fig. 3B, cf. day 0 and 2).

It is, however, of importance to note that the Ly-5.1+ V{alpha}14 NKT cells stayed alive even after {alpha}-GalCer-DC stimulation (Fig. 3B, day 0–4). As observed previously, {alpha}-GalCer/CD1d tetramer-reactive V{alpha}14 NKT cells reappeared on day 3 (Fig. 3B, day 3) and the number of Ly-5.1+ V{alpha}14 NKT cells subsequently expanded to account for >18% of total cultured cells (Fig. 3B, day 4). These results clearly demonstrated that Ly-5.1+ V{alpha}14 NKT cells down-regulate their invariant V{alpha}14 receptor upon {alpha}-GalCer stimulation, stay quiescent and eventually proliferate.

We also examined whether the observed cellular expansion accompanied cell division by labeling cells with CFSE. Electronically sorted liver NK1.1+TCRß+ cells from Ly-5.2 mice were labeled with CFSE and mixed with unfractionated Ly-5.1+ spleen cells. These mixtures were stimulated with {alpha}-GalCer or vehicle. It was not until 57 h after stimulation that cell division could be detected only in cells activated with {alpha}-GalCer (Fig. 3C, upper panel and data not shown). After that period, {alpha}-GalCer-stimulated cells continued to divide. In marked contrast, vehicle-stimulated V{alpha}14 NKT cells showed little, if any, cell division (Fig. 3C, lower panel). These results indicated that {alpha}-GalCer promotes V{alpha}14 NKT cell proliferation and further underpinned the above hypothesis.

V{alpha}14 NKT cells are relatively resistant to apoptosis induced by receptor activation
The above data, however, did not exclude the possibility that a limited number of V{alpha}14 NKT cells undergo apoptosis upon activation. We thus examined, by Annexin-V staining, whether V{alpha}14 NKT cells underwent apoptosis upon stimulation. A comparison of Annexin-V staining upon anti-CD3 mAb stimulation showed less staining for V{alpha}14 NKT cells relative to conventional T cells (TCRß+NK1.1) at all time points examined (Fig. 4A, left panel), suggesting that, albeit weakly, V{alpha}14 NKT cells underwent apoptosis upon receptor-mediated activation. The number of cells that underwent apoptosis was further evaluated by measuring the amount of released DNA fragments by ELISA. As in the case of Annexin-V staining, fragmented DNA was observed in some fractions of V{alpha}14 NKT cells, but the degree of fragmentation was less than that in conventional T cells (Fig. 4A, right panel).



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4. V{alpha}14 NKT cells are resistant to apoptotic cell death induced by receptor-mediated activation relative to conventional T cells. (A) Kinetics of apoptotic cell death induced by activation in V{alpha}14 NKT cells and conventional T cells. Annexin-V expression levels were analyzed in electronically sorted V{alpha}14 NKT cells and conventional T cells from the liver after stimulation with anti-CD3 mAb for the indicated periods of time. The percentage of Annexin-V-stained cells is shown as open circles for conventional T cells and closed circle for V{alpha}14 NKT cells (left panel). Apoptosis was also quantified by measuring the amounts of fragmented DNA from the cells using an ELISA kit (right panel). Representative data from two independent experiments are shown. (B) Apoptosis-related genes are differentially expressed in V{alpha}14 NKT cells stimulated for 2 h. V{alpha}14 NKT cells and conventional T cells were isolated and stimulated as described in (A). Total RNA was extracted and subjected to RNA amplification. After random priming, differential hybridization was performed. Upper panel: scattered plot analysis between NKT and conventional T cells. Lower left panel: differential hybridization signal on DNA array. The ratio represents the fold change of the hybridization signal between two groups in duplicate experiments after normalizing with the signal of HPRT. Lower right panel: RT-PCR detection for NAIP, MyD118 and IL-1ß in cells used for DNA array experiments. HPRT serves as a control to assure the equal amount of the recovered RNA. (C) Up-regulation of anti-apoptotic genes upon receptor activation in vivo. After in vivo stimulation with {alpha}-GalCer for the indicated periods of time, NKT cells from the spleen were electronically sorted. RNA was extracted from spleen NKT cells at the indicated time, and subjected to RT-PCR with primers for NAIP, MyD118 and IL-1ß. HPRT serves as control to ensure equal cDNA input in each lane. For comparison, RNA from the same number of conventional spleen T cells was subjected to RT-PCR without any stimulation.

 
To explore the molecular mechanisms underlying resistance to apoptosis in V{alpha}14 NKT cells, we compared the profile of apoptosis-related gene expression in V{alpha}14 NKT and conventional T cells through a DNA microarray study (Fig. 4B, upper panel and see Supplementary data). After stimulation with anti-CD3 mAb for 2 h, RNA was extracted from V{alpha}14 NKT cells and from conventional T cells, and subjected to differential hybridization. To compare the signal intensity, we used scattered plot analysis (Array-Gage; Fuji Film). When the signal was normalized with HPRT, several molecules showed increased hybridization signal in V{alpha}14 NKT cells relative to conventional T cells (Fig. 4B, upper and lower left panel). Subsequent semiquantitative RT-PCR analyses confirmed that NAIP and MyD118 were indeed up-regulated in V{alpha}14 NKT cells relative to conventional T cells (Fig. 4B, lower right panel). We have also examined several genes that showed reduced expression in V{alpha}14 NKT cells based on scattered plot data. It turned out that IL-1ß, an indicator of apoptosis, showed reduced hybridization signal concomitant with decreased mRNA expression as revealed by RT-PCR analysis when compared to conventional T cells (Fig. 4B, lower panels) (12). All gene expression profiles in V{alpha}14 NKT cells and in conventional T cells are available in the Supplementary data.

These differences in expression of apoptotic genes may reflect the intrinsic nature of each cell type. We also compared the expression of apoptosis-related genes in V{alpha}14 NKT cells and conventional T cells prior to receptor activation. It was found that the expression profile of these cells prior to receptor activation mirrored that of post-receptor stimulation (cf. Fig. 4B, lanes 3 and 4, and C, lanes 1 and 2). Further kinetic studies on the expression of the indicated genes in V{alpha}14 NKT cells in vivo revealed that, upon receptor activation, NAIP expression increased up to day 3, while expression thereafter gradually declined. MyD118 showed a similar expression pattern over time as NAIP, while the level of IL1-ß expression remained constant (Fig. 4C).

V{alpha}14 NKT cell resistance to tolerance induction after receptor down-regulation
Since the activation of T cells often results in the loss of their function and becomes tolerant (2), the ability of V{alpha}14 NKT cells to secrete IFN-{gamma} and IL-4 upon re-stimulation with {alpha}-GalCer-DC or vehicle-DC was examined at the indicated time points following the initial {alpha}-GalCer-DC stimulation. At any given time point, even after the down-regulation of the V{alpha}14 receptor, activated V{alpha}14 NKT cells produced both IFN-{gamma} and IL-4 upon re-stimulation with {alpha}-GalCer-DC (Fig. 5). In contrast, neither IFN-{gamma} nor IL-4 production could be observed following vehicle-DC re-stimulation (Fig. 5). These results indicate that the activation of V{alpha}14 NKT cells does not affect cytokine production in these cells after re-stimulation.



View larger version (13K):
[in this window]
[in a new window]
 
Fig. 5. Cytokine production from re-stimulated V{alpha}14 NKT cells. Total spleen cells were cultured in the presence of {alpha}-GalCer-DC as described in Fig. 2(B) for the indicated periods of time (day 0–5). Cells were then collected, washed and stimulated with vehicle-DC (–) or re-stimulated with {alpha}-GalCer-DC (+) for another 72 h. The concentration of IFN-{gamma} and IL-4 in the supernatant was determined by ELISA. Data from three independent experiments are shown with ± SD. The asterisks (* and **) indicate that the concentration was below the detection threshold for IFN-{gamma} (<0.16 ng/ml) or IL-4 (<15.6 pg/ml), respectively.

 

    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
We have demonstrated that V{alpha}14 NKT cell activation results in the subsequent down-regulation of the V{alpha}14 receptor. Activated V{alpha}14 NKT cells remain quiescent for a while, but eventually proliferate. However, the effector functions of activated V{alpha}14 NKT cells, such as cytokine production, remain intact even after receptor down-regulation. These unique features distinguish V{alpha}14 NKT cells from other types of effector T cells which are readily subjected to clonal deletion or anergy upon TCR-mediated activation.

Our present data are somewhat contradictory to the previous reports claiming that NKT cells, defined as NK1.1+TCRßdim cells, are extremely sensitive to IL-12- and TCR-induced apoptosis (13). This is most evident in our in vitro experiments where there is no provision of exogenous V{alpha}14 NKT cells or V{alpha}14 NKT cell progenitors (Fig. 2B). Under such conditions, the rapid disappearance and subsequent expansion of V{alpha}14 NKT cells upon {alpha}-GalCer challenge cannot be attributed to the immediate eradication of the cells by apoptosis. Rather, the seeming disappearance of V{alpha}14 NKT cells is better explained by the down-regulation of the V{alpha}14 receptor. This interpretation is further supported by transfer experiments using Ly-5.1+ cells and by kinetic PCR (Fig. 3). Still, more detailed studies are needed to elucidate the precise mechanism of V{alpha}14 NKT cell number reduction following receptor stimulation in vivo (Figs 1 and 2A). Apoptotic cell death may play a role in this process. However, since the expression of certain anti-apoptotic genes is up-regulated following receptor activation, it appears likely that NKT cells become less susceptible to apoptosis over time (see below, Fig. 4C).

The molecular mechanism underlying the resistance of V{alpha}14 NKT cells to TCR-mediated apoptosis was further explored by DNA microarray studies combined with RT-PCR analysis (Fig. 4B). Our results indicate that the resistance to apoptosis of V{alpha}14 NKT cells relative to conventional T cells is primarily due to the preferential expression of anti-apoptotic genes, such as NAIP and MyD118. NAIP belongs to the inhibitor of apoptosis (IAP) that regulates lymphocyte sensitivity to Fas-mediated apoptosis (3,14). IAP bind activated caspases, and target their ubiquitination and degradation via the baculovirus IAP repeat (BIR) motif, which eventually allows the cells to survive upon Fas-induced signals. MyD118, also known as Gadd45ß, was first identified as a member of the Gadd45 family associated with cell-cycle control and DNA repair (15,16). MyD118/Gadd45ß is induced by an apoptotic factor, tumor necrosis factor-{alpha}, and acts as an anti-apoptotic protein by inhibiting JNK activity (17). Since continuous activation of JNK activity is tightly correlated with apoptosis (18), its inhibition results in the blocking of apoptosis. In summary, the increased expression of anti-apoptotic genes post-receptor activation together with the unaltered expression of IL-1ß in V{alpha}14 NKT cells may explain, at least in part, why these cells are more resistant to apoptosis than conventional T cells. In the light of these data, it is not surprising that V{alpha}14 NKT cells are relatively resistant to apoptosis induced by irradiation and glucocorticoid treatment (19,20). Since conventional T cells comprise naive and memory cells, a more fine comparison in the expression of anti-apoptotic genes between V{alpha}14 NKT cells and conventional T cells will provide more insight into the anti-apoptotic mechanism in V{alpha}14 NKT cells.

Another unique facet of V{alpha}14 NKT cells is that its effector function, the production of cytokines, is kept intact even after activation (Fig. 5). This indicates that V{alpha}14 NKT cells do not become anergic upon receptor activation. In line with this, priming {alpha}-GalCer-pulsed DC in vivo followed by re-stimulation with {alpha}-GalCer-pulsed DC in vitro does not induce anergy in V{alpha}14 NKT cells (21). However, we have to mention that the amount of IL-4 produced by activated NKT cells was relatively constant regardless of the different NKT cell number (Figs 2A and 5). This may be explained, at least in part, by the fact that IL-4 produced from the activated NKT cells is consumed by NKT cells per se or B cells, thus culminating in the similar net production of IL-4 (22,23).

These distinct features of V{alpha}14 NKT cells may be tightly linked to the role of V{alpha}14 NKT cells in controlling and suppressing autoreactive effector T cells. Collectively, it is conceivable that the nature of V{alpha}14 NKT cells to be resistance to tolerance induction as well as apoptosis after down-regulation of the invariant V{alpha}14 receptor confers on these cells the ability to mediate a long-lasting regulatory function under any given circumstances.

These findings will open the door to the elucidation of the homeostasis of immunoregulatory cells.


    Acknowledgements
 
The authors thank Ms Hiroko Tanabe for the preparation of this manuscript and Kirin Brewery Co. Ltd for support of this study. This work was in part supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (Japan) through a grant under the Special Coordination Fund for the Promotion of Science and Technology (T. N.), and through Grants-in-Aid for Scientific Research C#13218016 (T. N.), A#13307011 (M. T.), B#14370107 (T. N.) and C#12670293 (T. N.); the Program for the Promotion of Fundamental Studies in Health Sciences, Organization for Pharmaceutical Safety and Research, Ministry of Health, Labor and Welfare (M. T.); and the Human Frontier Science Program, RG00168/2000-M206 (M. T).


    Abbreviations
 
{alpha}-GalCer—{alpha}-galactosylceramide

CFSE—carboxyfluorescein diacetate succinimidyl ester

DC—dendritic cell

IAP—inhibitor of apoptosis


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Lenardo, M., Chan, K. M., Hornung, F., McFarland, H., Siegel, R., Wang, J. and Zheng, L. 1999. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:221.[CrossRef][ISI][Medline]
  2. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21:305.[CrossRef][ISI][Medline]
  3. Rathmell, J. C. and Thompson, C. B. 2002. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109(Suppl.):S97.
  4. Banz, A., Pontoux, C. and Papiernik, M. 2002. Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells. J. Immunol. 169:750.[Abstract/Free Full Text]
  5. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W. and Sakaguchi, S. 2000. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303.[Abstract/Free Full Text]
  6. Shevach, E. M. 2002. CD4+CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389.[ISI][Medline]
  7. Lantz, O. and Bendelac, A. 1994. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD48 T cells in mice and humans. J. Exp. Med. 180:1097.[Abstract]
  8. Bendelac, A., Lantz, O., Quimby, M. E., Yewdell, J. W., Bennink, J. R. and Brutkiewicz, R. R. 1995. CD1 recognition by mouse NK1+ T lymphocytes. Science 268:863.[ISI][Medline]
  9. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y., Koseki, H., Kanno, M. and Taniguchi, M. 1997. Requirement for V{alpha}14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623.[Abstract/Free Full Text]
  10. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M. 1997. CD1d-restricted and TCR-mediated activation of V{alpha}14 NKT cells by glycosylceramides. Science 278:1626.[Abstract/Free Full Text]
  11. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. and Wakao, H. 2003. The regulatory role of V{alpha}14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483.[CrossRef][ISI][Medline]
  12. Rathmell, J. C. and Thompson, C. B. 1999. The central effectors of cell death in the immune system. Annu. Rev. Immunol. 17:781.[CrossRef][ISI][Medline]
  13. Eberl, G. and MacDonald, H. R. 1998. Rapid death and regeneration of NKT cells in anti-CD3{epsilon}- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 9:345.[ISI][Medline]
  14. Gotz, R., Karch, C., Digby, M. R., Troppmair, J., Rapp, U. R. and Sendtner, M. 2000. The neuronal apoptosis inhibitory protein suppresses neuronal differentiation and apoptosis in PC12 cells. Hum. Mol. Genet. 9:2479.[Abstract/Free Full Text]
  15. Wang, X. W., Zhan, Q., Coursen, J. D., Khan, M. A., Kontny, H. U., Yu, L., Hollander, M. C., O‘Connor, P. M., Fornace, A. J., Jr and Harris, C. C. 1999. GADD45 induction of a G2/M cell cycle checkpoint. Proc. Natl Acad. Sci. USA 96:3706.[Abstract/Free Full Text]
  16. Zhan, Q., Antinore, M. J., Wang, X. W., Carrier, F., Smith, M. L., Harris, C. C. and Fornace, A. J., Jr. 1999. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 18:2892.[CrossRef][ISI][Medline]
  17. De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R. and Franzoso, G. 2001. Induction of gadd45ß by NF-{kappa}B downregulates pro-apoptotic JNK signalling. Nature 414:308.[CrossRef][ISI][Medline]
  18. Chen, Y. R. and Tan, T. H. 2000. The c-Jun N-terminal kinase pathway and apoptotic signaling. Int. J. Oncol. 16:651.[ISI][Medline]
  19. Kimura, M., Watanabe, H., Ohtsuka, K., Iiai, T., Tsuchida, M., Sato, S. and Abo, T. 1993. Radioresistance of intermediate TCR cells and their localization in the body of mice revealed by irradiation. Microbiol. Immunol. 37:641.[ISI][Medline]
  20. Tamada, K., Harada, M., Abe, K., Li, T. and Nomoto, K. 1998. IL-4-producing NK1.1+ T cells are resistant to glucocorticoid-induced apoptosis: implications for the Th1/Th2 balance. J. Immunol. 161:1239.[Abstract/Free Full Text]
  21. Fujii, S., Shimizu, K., Kronenberg, M. and Steinman, R. M. 2002. Prolonged IFN-{gamma}-producing NKT response induced with {alpha}-galactosylceramide-loaded DCs. Nat. Immunol. 3:867.[CrossRef][ISI][Medline]
  22. Kaneko, Y., Harada, M., Kawano, T., Yamashita, M., Shibata, Y., Gejyo, F., Nakayama, T. and Taniguchi, M. 2000. Augmentation of V{alpha}14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191:105.[Abstract/Free Full Text]
  23. Yoshimoto, T., Min, B., Sugimoto, T., Hayashi, N., Ishikawa, Y., Sasaki, Y., Hata, H., Takeda, K., Okumura, K., Van Kaer, L., Paul, W. E. and Nakanishi, K. 2003. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice. J. Exp. Med. 197:997.[Abstract/Free Full Text]